Late relapses in acute myeloid leukemia: analysis of characteristics and outcome (Q33861781)

29 July 2017

title

Late relapses in acute myeloid leukemia: analysis of characteristics and outcome (English)

1 reference

29 July 2017

1 reference

acute myeloid leukemia

1 reference

2

Hagop Kantarjian

1 reference

29 July 2017

3

Stefan Faderl

1 reference

29 July 2017

9

Jorge Cortes

1 reference

29 July 2017

4

Susan O'Brien

1 reference

29 July 2017

10

Farhad Ravandi

1 reference

29 July 2017

5

Sherry Pierce

1 reference

29 July 2017

8

Michael Keating

1 reference

29 July 2017

1

Dushyant Verma

1 reference

29 July 2017

Khanh Vu

6

1 reference

29 July 2017

Emil Freireich

series ordinal

7

1 reference

29 July 2017

publication date

1 May 2010

1 reference

29 July 2017

1 reference

29 July 2017

volume

51

1 reference

29 July 2017

issue

5

1 reference

29 July 2017

page(s)

778-782

1 reference

Biology and management of relapsed acute myeloid leukaemia.

29 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4086357

Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4086357

The treatment of acute myeloid leukemia in first relapse: a comprehensive review of the literature

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4086357

Genetic pathways in therapy-related myelodysplasia and acute myeloid leukemia

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4086357

Late relapse following autologous bone marrow transplantation for acute myelogenous leukemia: case report and review of the literature

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4086357

The characteristics and outcome of patients with late relapse acute myelogenous leukemia

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4086357

Post-remission therapy of acute myelocytic leukemia in adults: curability breeds controversy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4086357

A randomized trial of high-versus conventional-dose cytarabine in consolidation chemotherapy for adult de novo acute myeloid leukemia in first remission after induction therapy containing high-dose cytarabine

5 July 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428191003661852

Characteristics and outcomes of acute myelogenous leukemia patients with very late relapse (>5 years).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428191003661852

Late relapse of acute myelogenous leukemia followed by epstein-barr virus-associated lymphoproliferative disease 11 years after allogeneic bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428191003661852

Late relapses evolve from slow-responding subclones in t(12;21)-positive acute lymphoblastic leukemia: evidence for the persistence of a preleukemic clone.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428191003661852

Relapsed acute myelogenous leukemia occurring after 18 years with recurrent novel chromosomal abnormality t(18;22)(q23;q11.2)

21 January 2018

1 reference

12 December 2020

Impact of cytogenetics on the prognosis of adults with de novo AML in first relapse

1 reference

12 December 2020

The frequency of long-term remission in patients with acute myelogenous leukaemia treated with conventional maintenance chemotherapy: a study of 760 patients with a minimal follow-up time of 6 years

1 reference

12 December 2020

Are patients with acute leukaemia, alive and well 2 years post bone marrow transplantation cured? A European survey. Acute Leukaemia Working Party of the European Group for Bone Marrow Transplantation (EBMT)

1 reference

12 December 2020

Long-term follow-up of Cancer and Leukemia Group B studies in acute myeloid leukemia

1 reference

12 December 2020

A systematic collaborative overview of randomized trials comparing idarubicin with daunorubicin (or other anthracyclines) as induction therapy for acute myeloid leukaemia. AML Collaborative Group

1 reference

12 December 2020

10.3109/10428191003661852

Identifiers

DOI

1 reference

29 July 2017

1 reference

29 July 2017

1 reference